Morphine



Combined with:

Yaz

Indications and Reactions:

Role Indications Reactions
Primary
Pain 34.1%
Drug Use For Unknown Indication 16.1%
Product Used For Unknown Indication 9.1%
Back Pain 5.3%
Procedural Pain 5.3%
Cancer Pain 3.8%
Postoperative Analgesia 2.9%
Neuralgia 2.8%
Induction Of Anaesthesia 2.5%
Maintenance Of Anaesthesia 2.1%
Drug Abuse 2.1%
Anaesthesia 2.0%
Spinal Anaesthesia 1.9%
Analgesia 1.7%
General Anaesthesia 1.6%
Hypertension 1.6%
Abdominal Pain 1.4%
Analgesic Therapy 1.4%
Sedative Therapy 1.2%
Breakthrough Pain 1.1%
Vomiting 9.6%
Completed Suicide 9.3%
Death 8.1%
Unresponsive To Stimuli 8.0%
Somnolence 7.6%
Cardio-respiratory Arrest 7.5%
Drug Abuse 6.7%
Drug Hypersensitivity 5.9%
Sedation 5.4%
Toxicity To Various Agents 5.0%
Overdose 3.6%
Medication Error 3.5%
Drug Ineffective 3.3%
Pruritus 3.1%
Respiratory Depression 2.8%
Urticaria 2.6%
Mental Status Changes 2.1%
Drug Toxicity 2.0%
Pulmonary Oedema 2.0%
Nausea 1.8%
Secondary
Product Used For Unknown Indication 34.8%
Drug Use For Unknown Indication 19.1%
Pain 18.7%
Cancer Pain 3.1%
Analgesic Therapy 2.9%
Anaesthesia 2.5%
Back Pain 2.4%
Drug Abuse 2.2%
Depression 2.0%
Hypertension 1.6%
Neuralgia 1.5%
Ill-defined Disorder 1.3%
Spinal Anaesthesia 1.3%
Procedural Pain 1.1%
Postoperative Analgesia 1.0%
Pain Management 1.0%
Sedation 1.0%
Hiv Infection 0.9%
Breakthrough Pain 0.9%
Constipation 0.8%
Toxicity To Various Agents 13.7%
Respiratory Arrest 10.5%
Vomiting 9.7%
Drug Abuse 8.8%
Completed Suicide 8.1%
Death 5.8%
Somnolence 5.5%
Poisoning 4.7%
Drug Toxicity 4.3%
Overdose 4.3%
Intentional Drug Misuse 3.3%
Drug Ineffective 2.8%
Pain 2.8%
Hypotension 2.5%
Sedation 2.4%
Cardio-respiratory Arrest 2.3%
Unresponsive To Stimuli 2.3%
Hyperaesthesia 2.1%
Venoocclusive Liver Disease 2.1%
Renal Failure 2.0%
Concomitant
Product Used For Unknown Indication 32.5%
Drug Use For Unknown Indication 21.0%
Pain 13.2%
Prophylaxis 4.6%
Hypertension 3.2%
Multiple Myeloma 3.0%
Nausea 3.0%
Constipation 2.5%
Depression 2.2%
Anxiety 1.7%
Back Pain 1.7%
Rheumatoid Arthritis 1.7%
Non-small Cell Lung Cancer 1.6%
Crohn's Disease 1.6%
Diabetes Mellitus 1.1%
Cancer Pain 1.1%
Insomnia 1.1%
Osteoporosis 1.1%
Breast Cancer 1.0%
Abdominal Pain 1.0%
Vomiting 16.9%
Weight Decreased 10.3%
Death 7.0%
Pain 6.7%
Pulmonary Embolism 5.5%
Sepsis 5.4%
Weight Increased 4.8%
Pneumonia 4.6%
Thrombocytopenia 4.4%
White Blood Cell Count Decreased 4.2%
Pyrexia 3.7%
Renal Failure Acute 3.5%
Somnolence 3.4%
Nausea 3.3%
Respiratory Failure 3.3%
Renal Failure 3.2%
Urinary Tract Infection 3.2%
Tremor 2.3%
White Blood Cell Count Increased 2.2%
Unresponsive To Stimuli 2.2%
Interacting
Product Used For Unknown Indication 24.4%
Drug Use For Unknown Indication 18.8%
Pain 13.9%
Anaesthesia 7.2%
Restlessness 5.8%
Femur Fracture 3.3%
Analgesic Effect 3.0%
Chemotherapy 2.8%
Hypertension 2.8%
General Anaesthesia 2.2%
Induction Of Anaesthesia 2.2%
Ankle Fracture 1.7%
Dyspnoea 1.7%
Hallucination 1.7%
Hepatitis C 1.7%
Restless Legs Syndrome 1.7%
Ex-smoker 1.4%
Malignant Hydatidiform Mole 1.4%
Neuralgia 1.4%
Abdominal Pain 1.1%
Drug Interaction 19.5%
Sedation 8.0%
Respiratory Depression 6.9%
Respiratory Failure 6.9%
Therapeutic Agent Toxicity 6.9%
Toxicity To Various Agents 6.9%
Somnolence 5.7%
Smoker 4.6%
Unresponsive To Stimuli 4.6%
Vomiting 4.6%
Respiratory Arrest 3.4%
Weight Decreased 3.4%
Confusional State 2.3%
Dehydration 2.3%
Drug Level Decreased 2.3%
Fall 2.3%
General Physical Health Deterioration 2.3%
Infectious Peritonitis 2.3%
Myoclonus 2.3%
Overdose 2.3%